HomeInvestors HealthAstraZeneca to buy EsoBiotec in $1 billion deal to advance cell therapy... AstraZeneca to buy EsoBiotec in $1 billion deal to advance cell therapy ambition (AZN:NASDAQ) By BOMAR ENT. March 17, 2025 FacebookTwitterPinterestWhatsApp Roland Magnusson EsoBiotec SA has entered into a definitive agreement to be acquired by AstraZeneca (NASDAQ:AZN) for up to $1 billion, on a cash and debt-free basis, it said on Monday. The deal includes an initial payment of $425 million on closing, and up Source link Previous articleBeating the StreetNext articleKnit Socks!: 17 Classic Patterns for Cozy Feet latest articles explore more Best Consumer Dividend Stocks to Buy Now: HAS, KVUE, MOV – June 4, 2026 Intelligent Investing: The #1 wealth building strategy Options Trading Crash Course: 2 BOOKS IN 1 (BEGINNERS and STRATEGIES), The Only Day, Swing and Binary Proven Strategies You Need to Trade in... Swing Trading for Beginners: The Simple Guide with Secret Strategies to Trade Stocks, ETFs, Options, Futures, Currencies and Cryptocurrencies. Make a Living and Create... The “Engine” of the U.S. Economy is Starting to Crack ‘Cow Vigilantes’ Get Catholics in Prayer Arrested in India LEAVE A REPLY Cancel reply Comment: Please enter your comment! Name:* Please enter your name here Email:* You have entered an incorrect email address! Please enter your email address here Website: Save my name, email, and website in this browser for the next time I comment.
